MENU

Amarin (AMRN) Earnings Date & Reports

A.I. Advisor
published Earnings

AMRN is expected to report earnings to rise 350.00% to -4 cents per share on July 31

Amarin AMRN Stock Earnings Reports
Q2'24
Est.
$-0.05
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.02
Q3'23
Est.
$-0.05
Q2'23
Beat
by $0.05
The last earnings report on May 01 showed earnings per share of 0 cents, beating the estimate of -2 cents. With 700.48K shares outstanding, the current market capitalization sits at 357.53M.
View a ticker or compare two or three
AMRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on commercialization and development of therapeutics to improve cardiovascular health

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
112-114 St Stephens Green
Phone
+353 16699020
Employees
275
Web
https://www.amarincorp.com